MaaT Pharma fetches Series B
MaaT Pharma, a French clinical-stage oncology company, has secured 18 million euros in Series B financing.
MaaT Pharma, a French clinical-stage oncology company, has secured 18 million euros in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination